Long Survival of a Small-Cell Lung Cancer Patient Who Received Maintenance Chemotherapy with Irinotecan

Long Survival of a Small-Cell Lung Cancer Patient Who Received Maintenance Chemotherapy with Irinotecan

Lung cancer is the leading cause of cancer-related death worldwide. Small-cell lung cancer (SCLC) accounts for approximately 15% of all lung cancers. It is characterized by rapid tumor growth and early metastasis to multiple organs. Response to initial chemotherapy is generally good; however, the ma...

Full description

Bibliographic Details
Main Authors: Yoshitaka Yagi, Young Hak Kim, Noriyuki Tajima, Kiichiro Baba, Kensaku Aihara, Hong Hyun Soo, Shinpachi Yamaoka, Michiaki Mishima
Format: Article
Language:English
Published: Karger Publishers 2013-11-01
Series:Case Reports in Oncology
Subjects:
Small-cell lung cancer
Irinotecan
Maintenance
Long survivor
Extensive disease
Online Access:http://www.karger.com/Article/FullText/356826

Similar Items

Similar Items